Robert Walczak

3.1k citations

26 papers · 2.6k indexed · 1 hit paper · h-index 15

Impact in

Biochemistry top 1%
- Lipid metabolism and biosynthesis
Surgery top 2%
- Cholesterol and Lipid Metabolism

Papers in

Toxicology 1
Molecular Biology 20
- Peroxisome Proliferator-Activated Receptors 8
- Retinoids in leukemia and cellular processes 3
- Redox biology and oxidative stress 3
- Fibroblast Growth Factor Research 2

Co-authors: Peter Tontonoz Bryan Laffitte Sean B. Joseph Jon L. Collins Philippe Carbon Alain Krol Damien C. Wilpitz Michael A. Watson
Journals: Journal of Hepatology (6 papers)Journal of Lipid Research (2 papers)Journal of Biological Chemistry (2 papers)Proceedings of the National Academy of Sciences (2 papers)SLAS DISCOVERY (1 paper)
Partner nations: France United States Japan

In The Last Decade

Robert Walczak

25 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors 2002 · 631 citations

Peers

Countries citing papers authored by Robert Walczak

Since Specialization

Citations

This map shows the geographic impact of Robert Walczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Walczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Walczak more than expected).

Fields of papers citing papers by Robert Walczak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Walczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Walczak. The network helps show where Robert Walczak may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert Walczak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Walczak Line = papers co-authored together Robert Walczak links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	1817-P: Elafibranor and Glucagon-Like Peptide-1 Receptor Agonists Synergize to Attenuate Hepatic Inflammation and Fibrosis in a Rodent Model of Obesity, Insulin Resistance, and NASH Diabetes ·Vanessa Legry, Émeline Descamps, P. Kohila, Nicolas Stankovic‐Valentin, Peggy Parroche, Diana R. Williams, Philippe Poulain, Bart Staels, Robert Walczak	2020	0
2	The combination of elafibranor and semaglutide drastically improves fibrosing steatohepatitis and distinctly modulates liver inflammatory signature Journal of Hepatology ·Vanessa Legry, Philippe Poulain, E.A. Rowe, Peggy Parroche, Émeline Descamps, L. Russell, Dean W. Hum, Bart Staels, Stephen A. Harrison, Rohit Loomba, Arun J. Sanyal, Vlad Ratziu, Robert Walczak	2020	1
3	FRI-355-Elafibranor, a drug candidate for first line NASH monotherapy and a universal backbone for drug combination treatment Journal of Hepatology ·Vanessa Legry, Émeline Descamps, Benoît Noël, Andrea Fernández Estebán, Diana R. Williams, L. Russell, Dean W. Hum, S. Megnien, Ruan Pablo Nunes. Araújo, Rohit Loomba, Iara Barbosa de Sousa, Herbert Scharnagl, Arun J. Sanyal, Robert Walczak	2019	2
4	Drug repurposing screen identifies novel small molecule compounds with potent antifibrotic properties Journal of Hepatology ·Coralie Bélanger, Andrea Fernández Estebán, Kamasuta Kamasuta, S R Santorum, Dean W. Hum, Bart Staels, Robert Walczak	2017	7
5	Combination drug therapy allows synergistic therapeutic dose reduction in NASH: a case study of elafibranor (GFT505) and an FXR agonist combination in a model of severe NASH Journal of Hepatology ·Vlad Ratziu, S. Harrison, Benoît Noël, LI Zun-jian, Diana R. Williams, Trusov IuS, Chantal Bélanger, A. Roudot, S. Megnien, Dean W. Hum, Bart Staels, Robert Walczak, A. Sanyal	2017	1
6	RORgt Inhibition in the Liver Prevents Hepatic Fibrosis Progression, a Proof of Concept Study with a Potent, First in Class, Hepatocentric RORgt Inverse Agonist Journal of Hepatology ·Zouher Majd, J.-F. Delhomel, Philippe Delataille, Hongnan Ye, T. Condom, CUR, Bart Staels, Robert Walczak	2016	2
7	Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits Molecular Neurobiology ·Markus P. Kummer, Nur’aini Alprita, 秀全杜, S R Santorum, Robert Walczak, Dean W. Hum, Stephanie Schwartz, Aisha Haynes, Michael T. Heneka	2014	41
8	The Identification of Naturally Occurring Neoruscogenin as a Bioavailable, Potent, and High-Affinity Agonist of the Nuclear Receptor RORα (NR1F1) SLAS DISCOVERY ·Stéphane Helleboid, 章海源, Kai Lamottke, Samira Mirzavand, Βαρβάρα Δεμερτζίδου, Yoannes Bosco Candrasuryya Mahendra, S. Edlbacher, LI Zun-jian, Dean W. Hum, Robert Walczak	2013	38
9	Factors with an influence on mammalian oocytes developmental potential in light of molecular and microfluidic research. Medycyna Weterynaryjna ·Toni Pesonen, H. Piotrowska, Robert Walczak, 平尾友孝, Jan Dziuban, Dorota Bukowska, Paweł Antosik, M. Jackowska, M. Woźna, J. M. Jaśkowski	2011	3
10	Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target Journal of Lipid Research ·Cynthia Hong, Robert Walczak, Helena Dhamko, Michelle N. Bradley, Chaitra Marathe, Rima Boyadjian, Jon Salazar, Peter Tontonoz	2010	59
11	The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes Biochemical Journal ·Takeshi Murakami, Robert Walczak, Sandrine Caron, Christian Duhem, Vincent Vidal, Raphaël Darteil, Bart Staels	2007	16
12	Transcription of the Vascular Endothelial Growth Factor Gene in Macrophages Is Regulated by Liver X Receptors Journal of Biological Chemistry ·Robert Walczak, Sean B. Joseph, Bryan Laffitte, Antonio Castrillo, Liming Pei, Peter Tontonoz	2004	61
13	Setting fat on fire Nature Medicine ·Robert Walczak, Peter Tontonoz	2003	5
14	Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors Journal of Biological Chemistry ·Sean B. Joseph, Bryan Laffitte, Parthive H. Patel, Michael A. Watson, Karen Matsukuma, Robert Walczak, Jon L. Collins, Timothy F. Osborne, Peter Tontonoz Hit paper breakdown →	2002	631
15	PPARadigms and PPARadoxes: expanding roles for PPARγ in the control of lipid metabolism Journal of Lipid Research ·Robert Walczak, Peter Tontonoz	2002	228
16	Identification of macrophage liver X receptors as inhibitors of atherosclerosis Proceedings of the National Academy of Sciences ·Rajendra K. Tangirala, Eric D. Bischoff, Sean B. Joseph, Brandee Wagner, Robert Walczak, Bryan Laffitte, Chris Daige, Diane Thomas, Richard A. Heyman, David J. Mangelsdorf, Xuping Wang, Aldons J. Lusis, Peter Tontonoz, Ira G. Schulman	2002	359
17	Autoregulation of the Human Liver X Receptor α Promoter Molecular and Cellular Biology ·Bryan Laffitte, Sean B. Joseph, Robert Walczak, Liming Pei, Damien C. Wilpitz, Jon L. Collins, Peter Tontonoz	2001	270
18	A Protein Binds the Selenocysteine Insertion Element in the 3'-UTR of Mammalian Selenoprotein mRNAs Nucleic Acids Research ·Nicolas Hubert, Robert Walczak, Philippe Carbon, Alain Krol	1996	49
19	RNAs mediating cotranslational insertion of selenocysteine in eukaryotic selenoproteins Biochimie ·Nadia Hubert, Robert Walczak, John E. M. Goldsmith, Evelyne Myslinski, Catherine Schuster, Éric Westhof, Philippe Carbon, Alain Krol	1996	23
20	IS911-mediated Transpositional Recombinationin Vitro Journal of Molecular Biology ·Patrice Polard, Al-Rimawi, Laurence Haren, Mireille Bétermier, Robert Walczak, Michaël Chandler	1996	51

About Robert Walczak

Robert Walczak is a scholar working on Toxicology, Molecular Biology, Biochemistry, Nutrition and Dietetics and Hepatology, having authored 26 papers that have together received 2.6k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (8 papers), Cholesterol and Lipid Metabolism (6 papers), Selenium in Biological Systems (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Retinoids in leukemia and cellular processes (3 papers), Redox biology and oxidative stress (3 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Biochemistry (320 citations), Surgery (1.4k citations), Molecular Biology (1.5k citations), Cancer Research (328 citations) and Oncology (582 citations). Robert Walczak has collaborated with scholars based in France, United States and Japan. Frequent co-authors include Peter Tontonoz, Bryan Laffitte, Sean B. Joseph, Jon L. Collins, Philippe Carbon, Alain Krol, Damien C. Wilpitz, Michael A. Watson, Timothy F. Osborne and Karen Matsukuma. Their work appears in journals such as Journal of Hepatology, Journal of Lipid Research, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences and SLAS DISCOVERY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact